SciSparc Ltd. Shareholders Approve All Proposals at Meeting
Ticker: SPRC · Form: 6-K · Filed: Aug 26, 2025 · CIK: 1611746
| Field | Detail |
|---|---|
| Company | Scisparc Ltd. (SPRC) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
TL;DR
SciSparc shareholders greenlit all proposals at the Aug 26 meeting.
AI Summary
SciSparc Ltd. announced on August 26, 2025, that its shareholders approved all proposals at the adjourned special general meeting. The company, formerly known as Therapix Biosciences Ltd., is headquartered in Tel Aviv, Israel.
Why It Matters
Shareholder approval of all proposals is a crucial step for the company to proceed with its strategic and operational plans.
Risk Assessment
Risk Level: low — The filing is a routine announcement of shareholder meeting outcomes and does not introduce new financial or operational risks.
Key Players & Entities
- SciSparc Ltd. (company) — Filer and subject of the report
- Therapix Biosciences Ltd. (company) — Former company name
- August 26, 2025 (date) — Date of the special general meeting
FAQ
What was the purpose of the special general meeting of shareholders held on August 26, 2025?
The purpose was for shareholders to vote on proposals brought before the meeting.
Did SciSparc Ltd. change its name previously?
Yes, SciSparc Ltd. was formerly known as Therapix Biosciences Ltd. before a name change on January 29, 2021.
Where is SciSparc Ltd. headquartered?
SciSparc Ltd. is headquartered at 20 Raul Wallenberg Street, Tower A, Tel Aviv, Israel.
What type of filing is this report?
This is a Form 6-K, Report of Foreign Private Issuer.
Which SEC Act does this filing pertain to?
This filing pertains to the Securities Exchange Act of 1934.
Filing Stats: 308 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2025-08-26 16:00:25
Filing Documents
- ea0254681-6k_scisparc.htm (6-K) — 11KB
- 0001213900-25-080737.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SciSparc Ltd. Date: August 26, 2025 By: /s/ Oz Adler Name: Oz Adler Title : Chief Executive Officer 2